How big is the Asia-Pacific Mammography Market?

The Asia-Pacific Mammography Market size is expected to reach USD 521.17 million in 2024 and grow at a CAGR of 9.87% to reach USD 834.41 million by 2029. Read More

What is the current Asia-Pacific Mammography Market size?

In 2024, the Asia-Pacific Mammography Market size is expected to reach USD 521.17 million. Read More

Who are the key players in Asia-Pacific Mammography Market?

Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V. and Siemens Healthineers AG are the major companies operating in the Asia-Pacific Mammography Market. Read More

What years does this Asia-Pacific Mammography Market cover, and what was the market size in 2023?

In 2023, the Asia-Pacific Mammography Market size was estimated at USD 474.35 million. The report covers the Asia-Pacific Mammography Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Mammography Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia Pacific Mammography Market Trends

Asia Pacific Mammography Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Asia Pacific Mammography Market is segmented by Product (Digital Systems, Analog Systems, Breast Tomosynthesis, and Other Products), End Users (Hospitals, Diagnostic Centers and Other End Users), and Geography. The market provides the value (in USD million) for the above-mentioned segments.

Asia-Pacific Mammography Industry Overview

The Asia-Pacific mammography market is competitive and consists of several players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the region. Some of the companies which are currently dominating the market are Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical, Inc., and Allergan PLC.